Literature DB >> 3045003

Isolation of Shiga toxin-resistant Vero cells and their use for easy identification of the toxin.

U Kongmuang1, T Honda, T Miwatani.   

Abstract

Shiga toxin-resistant Vero cells were isolated by treatment of the cells with nitrosoguanidine. These mutant cells were not affected by Shiga toxin at more than 1 microgram/ml, although the parent Vero cells were sensitive to 25 pg of the toxin per ml. Immunofluorescence studies showed that all the mutant cells had lost toxin-binding capacity. The cytotoxic activities of various bacterial cultures against the parent and mutant cells were compared. All samples from 10 strains of Shigella dysenteriae type 1 and all three strains of Escherichia coli O157:H7 tested showed cytotoxicity to the parent cells but not to the mutant cells. Samples from other organisms, such as Shigella flexneri, Shigella sonnei, Clostridium difficile, Aeromonas hydrophila, Aeromonas sobria, and other E. coli strains, either had no effect or were cytotoxic on both the parent and mutant cells. Thus, these mutant cells could be used to identify Shiga-like toxin and distinguish it from other cytotoxins. The results also suggest the presence of a receptor for Shiga-like toxin on Vero cells that is essential for expression of the cytotoxicity of Shiga toxin but is not essential for growth of Vero cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3045003      PMCID: PMC259593          DOI: 10.1128/iai.56.9.2491-2494.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

Authors:  Y Endo; K Tsurugi; T Yutsudo; Y Takeda; T Ogasawara; K Igarashi
Journal:  Eur J Biochem       Date:  1988-01-15

2.  Interaction of Shigella shigae cytotoxin with receptors on sensitive and insensitive cells.

Authors:  K Eiklid; S Olsnes
Journal:  J Recept Res       Date:  1980

3.  Inhibition of protein synthesis by Shiga toxin: activation of the toxin and inhibition of peptide elongation.

Authors:  J E Brown; M A Ussery; S H Leppla; S W Rothman
Journal:  FEBS Lett       Date:  1980-08-11       Impact factor: 4.124

Review 4.  Shigella toxin(s): description and role in diarrhea and dysentery.

Authors:  G T Keusch; A Donohue-Rolfe; M Jacewicz
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

5.  Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin.

Authors:  A D O'Brien; M E Chen; R K Holmes; J Kaper; M M Levine
Journal:  Lancet       Date:  1984-01-14       Impact factor: 79.321

6.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  Quantitative microtiter cytotoxicity assay for Shigella toxin.

Authors:  M K Gentry; J M Dalrymple
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

8.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

9.  Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck; M R Thompson; S B Formal
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

10.  The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit.

Authors:  R Reisbig; S Olsnes; K Eiklid
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

View more
  2 in total

1.  Resistance to the Bacillus sphaericus toxin in cultured mosquito cells.

Authors:  J M Schroeder; C Chamberlain; E W Davidson
Journal:  In Vitro Cell Dev Biol       Date:  1989-10

2.  Induction of Neutrophil Extracellular Traps in Shiga Toxin-Associated Hemolytic Uremic Syndrome.

Authors:  Maria Victoria Ramos; Maria Pilar Mejias; Florencia Sabbione; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Maria Marta Amaral; Ramon Exeni; Analia Silvina Trevani; Marina Sandra Palermo
Journal:  J Innate Immun       Date:  2016-05-28       Impact factor: 7.349

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.